
| World
Health Authority Backs Research Posted: May 17th, 2008 |
Hopes of a fast track introduction of XL-6 through medical trials were dashed when back in September 2007, the Bush administration signed a legislation banning the use of three of the five listed stem cells needed to proceed with testing. However, Amcalon recently introduced the test drug into Europe via Germany and Spain and also South America via Peru. It's success in a well publicized recovery by recent reanimate attack victim Silke Koch (21) in Hannover, Germany has caught the attention of the world press. There has been no statement from Amcalon at this point in regards to when phase three (of four) testing will begin. Source: http://amcaloncorporation.com/Press_releases.php
|
Copyright 2007 ZombieWorldNews.com. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. |
| ZombieWorldNews.com |
| |
| ZWN
Financial Reports
Stay up to date with the latest financial news from ZWN |
| Archive
Reports |
| Medical
manufacturers rally to Food
giant collapses amid Opportunities
As New |
| |
| NIKKEI
12,545.23 -298.22 -1.76% HANG SENG 24,709.02 -356.96 -1.32% |
|
| OIL
- 0.71 0.78% = $90.13 10YR 30/32 105 4/32 = Yield: 3.62% |
| This site is for entertainment purposes only. All stories and events are fictional. Any similarities with persons either living or deceased in purely coincidental. Contents of this site are copyrighted. All rights reserved. |
![]() |